SCHEMBL20657281

SCHEMBL20657281

O=C(C=Cc1ccccc1)Nc1ccc(S(=O)(=O)N2CCCc3ccccc32)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.69
MEN1 O00255 8/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
LMNA P02545 5/20 0.66
MAPT P10636 5/20 0.66
TSHR P16473 2/20 0.66
NPC1 O15118 1/20 0.66
ALDH1A1 P00352 4/20 0.61
STAT3 P40763 1/20 0.61
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
TP53 P04637 1/20 0.54
AKR1C3 P42330 1/20 0.53
GAA P10253 2/20 0.52
HTT P42858 2/20 0.52
HCRTR1 O43613 1/20 0.52
USP2 O75604 1/20 0.52
PKM P14618 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30557964 1.00 KMT2A (0.69) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20657280 1.00 KMT2A (0.69) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20669354 0.94 KMT2A (0.67) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20657363 0.92 KMT2A (0.64) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL30557966 0.92 KMT2A (0.64) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20657362 0.92 KMT2A (0.64) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20669407 0.88 KMT2A (0.63) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20669435 0.86 KMT2A (0.63) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20669386 0.86 KMT2A (0.68) KMT2AMEN1SMN1; SMN2LMNAMAPT
SCHEMBL20669469 0.83 KMT2A (0.60) KMT2AMEN1SMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278971-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES VERSITECH LIMITED (HK) 2023-09-07 US disclosed
US-20210309622-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES VERSITECH LIMITED (HK) 2021-10-07 US disclosed
US-11052078-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases VERSITECH LIMITED (CN) 2021-07-06 US disclosed
US-11040949-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases VERSITECH LIMITED (CN) 2021-06-22 US disclosed
US-20200392095-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES THE UNIVERSITY OF HONG KONG (HK) 2020-12-17 US disclosed
US-20200261438-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES THE UNIVERSITY OF HONG KONG (HK) 2020-08-20 US disclosed
US-20190022038-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES VERSITECH LIMITED (HK) 2019-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11040949-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885
US-20200392095-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885
US-11052078-B2 Compounds affecting pigment production and methods for treatment of bacterial diseases TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885
US-20210309622-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885
US-20200261438-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885
US-20230278971-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885
US-20190022038-A1 COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES TYR, ALAD, NQO1 KMT2A 2724/4885MEN1 1255/4885SMN1; SMN2 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.